Journal of Clinical and Transnational Medical Sciences

The journal welcomes advanced research related to cancer biology, medical oncology, radiation oncology, surgical oncology, tumor immunology, cancer genomics, molecular therapeutics, and precision cancer medicine. Contributions integrating oncology with artificial intelligence, genomic analytics, biomarker discovery, translational therapeutics, and personalized treatment systems are highly encouraged. Emerging future directions include AI-assisted cancer diagnostics, intelligent tumor-profiling systems, targeted molecular therapies, precision immuno-oncology platforms, predictive cancer-risk analytics, and digitally integrated oncology-care infrastructures designed to improve early detection, treatment precision, and long-term patient survival.

The journal further supports interdisciplinary investigations involving tumor microenvironment research, cancer pharmacology, cellular oncology, metastatic disease mechanisms, regenerative cancer therapeutics, and technology-enabled oncology innovation. Research that combines oncology with computational medicine, biotechnology, nanomedicine, robotic surgery, and cutting-edge diagnostic systems is highly regarded. Emerging research areas include smart radiotherapy technologies, adaptive cancer-monitoring systems, AI-driven pathology imaging, personalized therapeutic engineering, and integrated precision-oncology ecosystems supporting sustainable cancer care, translational innovation, and future-ready global oncology healthcare systems.